Volume 180, Issue 4 p. 949
Letter to the Editor

Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients’ compliance

C. Marasca

Corresponding Author

C. Marasca

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy

Search for more papers by this author
A. Masarà

A. Masarà

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy

Search for more papers by this author
M.C. Annunziata

M.C. Annunziata

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy

Search for more papers by this author
V. Bettoli

V. Bettoli

Section of Dermatology, Department of Medical Sciences, University of Ferrara, Arcispedale S. Anna, Ferrara, Italy

Search for more papers by this author
M.A. Luciano

M.A. Luciano

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy

Search for more papers by this author
G. Fabbrocini

G. Fabbrocini

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via Pansini 5, Napoli, Italy

Search for more papers by this author
First published: 15 November 2018
Citations: 11
Funding sources: none.
Conflicts of interest: none to declare.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.